Suppose a genetic engineering breakthrough made it simple, safe and cheap to increase people's intelligence. Nonetheless, if you asked the averagely-intelligent person on the Clapham Omnibus whether we should tamper with our genes to boost our brains, he or she might recoil at the notion. Nick Bostrom, director of the Future of Humanity Institute at Oxford University, suspects that this reaction may be a result of what he calls 'status-quo bias'. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/

Trust

Bioethics is the study of the moral implications of new and emerging medical technologies and looks to answer questions such as selling organs, euthanasia and whether should we clone people. The series consists of a series of interviews by leading bioethics academics and is aimed at individuals looking to explore often difficult and confusing questions surrounding medical ethics. The series lays out the issue in a clear and precise way and looks to show all sides of the debate.